Berdagang AbbVie ABBV

Jual
 Beli

AbbVie carta live

5m 15m 30m 1h 4h 1d 1w

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

Berita Terkini

Frances Wang 2025 Mar 25, 16:00

Central Banks Weigh Interest Rate Moves Amid Inflation Debate

Fed
Tommy Yap 2025 Mar 25, 16:00

Morning Note: S&P 500 Surges on Tariff Optimism as Tesla Jumps 10%

Morning Note S&P 500 TSLA Oil
Tommy Yap 2025 Mar 25, 16:00

Morning Note: Australia’s Inflation Cools, Japan’s Stays High, UK Awaits Data

Morning Note AUD USD JPY GBP
Frances Wang 2025 Mar 24, 16:00

Pepe coin news today: where will Pepe coin price go in 2025?

Cryptocurrencies
Frances Wang 2025 Mar 24, 16:00

USD/JPY news today: Will USD/JPY Break 150?

Forex
Tommy Yap 2025 Mar 23, 16:00

Morning Note: Nvidia’s $1 Trillion Data Centre Bet, SEC Crypto Rules, US PMI Data

Morning Note NVDA Cryptocurrencies CPI
Tommy Yap 2025 Mar 22, 16:00

Week Ahead: Investor Eyes on U.S. Inflation & Core PCE for Fed’s Next Move

Forex Indices
Frances Wang 2025 Mar 20, 16:00

Stock indices news: US stock indices rose on Fed decision

Indices

Maklumat

Sebaran nilai

1.35

Spread (%)

0.6727 %

Leveraj

1:10

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran ditutup

Khamis

13:31 - 19:59

Isnin

13:31-19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Jumaat

13:31-19:59

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

356166434816

Saham Tertunggak

1768979968

Tarikh Pendapatan (Seterusnya)

0000-00-00

Hasil Div

2025-05-15

Tarikh Selepas Dividen

2025-04-15

Kadar dividen tahunan depan

6.56

Hasil dividen tahunan depan

0.0326

EPS

2.4

Ketahui lebih lanjut mengenai instrumen ini

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Instrumen Berkaitan

Aset
Jual
Beli
Perubahan (%):

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang
Instrumen Berkaitan
Trustpilot